Patent №
US 11,710,565
Granted
2023-07-25
Filed 2018
Owner
GENOMECARE CO., LTD
+1 more
Lab
—
AI components
2
ml · evo
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
16071883
Provided are a method of detecting chromosomal aneuploidy of a targeted fetal chromosome, and a computer-readable medium having recorded thereon a program to be applied to performing the method. According to the present disclosure, fetal chromosomal aneuploidy may be non-invasively and prenatally diagnosed with excellent sensitivity and specificity.
Machine learningEvolutionary computationG16H 50/20C12Q 1/6806C12Q 1/6827G06F 17/18G16B 20/00G16B 20/10G16B 20/20G16B 30/00+4 more
AI classification
Machine learning0.98
Evolutionary computation0.97
Vision0.00
Planning0.00
Speech0.00
Natural language0.00
AI hardware0.00
Knowledge representation0.00
Ownership
GENOMECARE CO., LTD
assignment · 464180609
THERAGEN GENOMECARE CO., LTD.
namechg · 470520029